Article Title

How should we conduct and interpret phase III clinical trials in palliative care?

Abstract

The article by Wildiers et al.1 raises some challenges in terms of ethical approaches to phase III end-of-life studies and their interpretation. Although the authors should be commended for undertaking a large, multisite, randomized, controlled trial in palliative care, there are fundamental questions that do need to be addressed before the first steps can be taken to adopt the study's findings into practice.

Keywords

peer-reviewed

 

Link to Publisher Version (DOI)

http://doi.org/10.1016/j.jpainsymman.2009.08.003